Paracervical Block Before Intrauterine Device (IUD) Insertion
- Conditions
- Pain Control for Intrauterine Device Insertions
- Interventions
- Registration Number
- NCT01207401
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to evaluate if a paracervical block containing 1% lidocaine administered prior to IUD insertion reduces insertion pain. The hypothesis is that women receiving paracervical analgesia will experience less pain during IUD insertion than those who do not receive such analgesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 50
- Women age 18 -50 years
- A negative urine pregnancy test and clinically unlikely to be pregnant
- Seeking an intrauterine device for any indication
- Willing and able to sign an informed consent in English
- History of a prior IUD successful insertion
- Previous failed insertion of an IUD
- Known copper allergy
- Known levonorgestrel allergy
- Known lidocaine allergy
- Current cervicitis
- Pelvic Inflammatory Disease (PID) within 3 months
- Pregnancy within six weeks prior to IUD insertion
- Uterine anomaly or distortion of the uterine cavity
- Use of any other pain medication within 6 hours prior to IUD insertion
- Use of misoprostol within 24 hours prior to IUD insertion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Paracervical Block Lidocaine -
- Primary Outcome Measures
Name Time Method Median Visual Analogue Score Measuring Pain 1) Speculum placement 2) Tenaculum placement 3) Paracervical block administration(if subject is in this arm) 4) IUD insertion 5) Five minutes post procedure We asked participants to report their pain score on visual analogue scale (0mm=no pain and 100mm=worse pain possible) at the following time points:
1. Speculum placement
2. Tenaculum placement
3. Paracervical block administration(if subject is in this arm)
4. IUD insertion
5. Five minutes post procedure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Northwestern Medical Faculty Foundation or Prentice Ambulatory Care Clinic
🇺🇸Chicago, Illinois, United States